No sugarcoating it: Improve diabetes screening compliance to get claims right

Why This Topic Matters

Claims for routine diabetes testing are frequently denied when billing does not align with coverage frequency, documentation, or payer-specific requirements. Understanding the policy framework helps practices reduce denials and support compliant reporting.

Article Sections

1. Coverage and denial context

   Introduces the denial problem and frames the billing issues around diabetes testing claims. It references Medicare claims activity and the need to align claims with coverage expectations.

2. Medicare coverage guidance and local policy checks

   Summarizes national and local coverage policy sources related to glycated hemoglobin testing. It emphasizes reviewing applicable Medicare contractor policies for current requirements.

3. Testing frequency and medical necessity

   Discusses general timing expectations for A1c testing and the circumstances that can affect whether additional testing is supported. It also addresses how changes in treatment or health status may alter coverage review.

4. Diagnosis support and diabetes-related scenarios

   Covers the role of diagnosis coding in supporting claims, including broad categories of uncontrolled diabetes and diabetes in pregnancy. The section highlights that diagnosis selection can affect whether testing frequency is supported.

5. Office laboratory reporting requirements

   Addresses office-based testing and the requirement to include the appropriate laboratory-related modifier when applicable. It ties the discussion to waived testing and CLIA-related billing context.

6. Payer-specific category II code requirements

   Describes private payer practices that may require additional reporting elements on claims. It notes that payer policies can differ from Medicare and may affect reimbursement workflows.